Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of diabetes and its complications

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jdiacomp.2017.08.009PMID 29037450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.

  2016cited by this paper
• Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.

  2016cited by this paper
• Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes

  2015cited by this paper
• Renal histologic changes and the outcome in patients with diabetic nephropathy.

  2015influential reference
• Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy

  2015cited by this paper
• Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes

  2015cited by this paper
• TNF receptors: signaling pathways and contribution to renal dysfunction.

  2015cited by this paper
• RELEVANCE OF TNF-α IN THE CONTEXT OF OTHER INFLAMMATORY CYTOKINES IN THE PROGRESSION OF DIABETIC NEPHROPATHY

  2015cited by this paper
• Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.

  2014cited by this paper
• Changes in diabetes-related complications in the United States, 1990-2010.

  2014cited by this paper
• Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?

  2013cited by this paper
• Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.

  2012cited by this paper
• The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease

  2012cited by this paper
• Early renal function decline in type 2 diabetes.

  2012cited by this paper
• Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats.

  2012cited by this paper
• The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP

  2012influential reference
• Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

  2012cited by this paper
• Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.

  2011cited by this paper
• Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes

  2011cited by this paper
• Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

  2011cited by this paper
• Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus.

  2011cited by this paper
• Neutrophil Gelatinase‐Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril

  2010influential reference
• The use of targeted biomarkers for chronic kidney disease.

  2010cited by this paper
• Pathologic classification of diabetic nephropathy.

  2010cited by this paper
• The role of tubular injury in diabetic nephropathy.

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study

  2009cited by this paper
• Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients

  2009cited by this paper
• Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension.

  2009cited by this paper
• The role of inflammatory cytokines in diabetic nephropathy.

  2008cited by this paper
• Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.

  2007cited by this paper
• Efficacy and safety of benazepril for advanced chronic renal insufficiency.

  2006cited by this paper
• How does proteinuria cause progressive renal damage?

  2006cited by this paper
• Tubular changes in early diabetic nephropathy.

  2005cited by this paper
• The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

  2003cited by this paper
• Regression of microalbuminuria in type 1 diabetes.

  2003cited by this paper
• Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.

  2002cited by this paper
• Progression of diabetic nephropathy.

  2001cited by this paper
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

  2001cited by this paper
• The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

  1999cited by this paper
• Proximal tubular basement membrane width in insulin-dependent diabetes mellitus.

  1998cited by this paper

• Metabolic syndrome and chronic kidney disease: the relationship of the leading components of metabolic syndrome with kidney damage and the features of their drug correction

  2025cites this paper
• Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four Cohorts.

  2025cites this paper
• Iron Metabolism and Ferroptosis in Diabetic Kidney Disease

  2025cites this paper
• Machine learning-based prediction of tubulointerstitial lesions in diabetic kidney disease: a multicenter validation study

  2025cites this paper
• Morin hydrate prevents diabetic nephropathy by suppressing oxidative stress and 8-hydroxydeoxyguanosine in kidney tissues

  2025cites this paper
• Swietenine attenuates renal tubular injury by activating mitophagy in diabetic nephropathy.

  2025cites this paper
• Novel Insights into Diabetic Kidney Disease

  2024influential citation
• Butyrate modulates gut microbiota and anti-inflammatory response in attenuating cisplatin-induced kidney injury.

  2024cites this paper
• Network for Pancreatic Organ donors with Diabetes-Kidney

  2024cites this paper
• Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients

  2024cites this paper
• Diagnostic value of α1-MG and URBP in early diabetic renal impairment

  2023cites this paper
• Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms

  2023cites this paper
• Clinical significance of Interleukin 17 receptor E in diabetic nephropathy.

  2023cites this paper
• Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease

  2022cites this paper
• Asiatic acid attenuates tubular injury in diabetic kidney disease by regulating mitochondrial dynamics via the Nrf-2 pathway.

  2022cites this paper
• Retracted: Value Analysis of Using Urinary Microalbumin in Artificial Intelligence Medical Institutions to Detect Early Renal Damage in Diabetes

  2022cites this paper
• Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review

  2022cites this paper
• Renoprotective Effect of Vardenafil and Avanafil in Contrast-Induced Nephropathy: Emerging Evidence from an Animal Model

  2022cites this paper
• The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD

  2022cites this paper
• Novel biomarkers for prognosticating diabetic kidney disease progression

  2022influential citation
• IgG subclass deposition in diabetic nephropathy

  2022cites this paper
• Effects and Mechanism of Ganoderma lucidum Polysaccharides in the Treatment of Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats

  2022cites this paper
• Mitochondria in Diabetic Kidney Disease

  2021cites this paper
• Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study

  2021cites this paper
• The Role of the Interplay Between Autophagy and NLRP3 Inflammasome in Metabolic Disorders

  2021cites this paper
• Value Analysis of Using Urinary Microalbumin in Artificial Intelligence Medical Institutions to Detect Early Renal Damage in Diabetes

  2021cites this paper
• Role of Urinary Beta 2 Microglobulin and Kidney Injury Molecule-1 in Predicting Kidney Function at One Year Following Acute Kidney Injury

  2021cites this paper
• Administration of Lactobacillus reuteri Combined with Clostridium butyricum Attenuates Cisplatin-Induced Renal Damage by Gut Microbiota Reconstitution, Increasing Butyric Acid Production, and Suppressing Renal Inflammation

  2021cites this paper
• The Complex Interplay between Autophagy and NLRP3 Inflammasome in Renal Diseases

  2021cites this paper
• Parkin ubiquitinates GATA4 and attenuates the GATA4/GAS1 signaling and detrimental effects on diabetic nephropathy

  2020cites this paper
• trans-Chalcone inhibits high-fat diet-induced disturbances in FXR/SREBP-1c/FAS and FXR/Smad-3 pathways in the kidney of rats.

  2020cites this paper
• IgG Subclass Expression in Diabetic Nephropathy

  2020cites this paper
• Renal expression of cytokines and chemokines in diabetic nephropathy

  2020cites this paper
• Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy

  2020cites this paper
• Glucose Induces IL-1α-Dependent Inflammation and Extracellular Matrix Proteins Expression and Deposition in Renal Tubular Epithelial Cells in Diabetic Kidney Disease

  2020cites this paper
• Blood and urine biomarkers in chronic kidney disease: An update.

  2019cites this paper
• Effect of miR-29c on renal fibrosis in diabetic rats via the AMPK/mTOR signaling pathway.

  2019cites this paper
• Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy

  2019cites this paper
• STORIA NATURALE DELLA MALATTIA RENALE NEL DIABETE E TRATTAMENTO DELL’IPERGLICEMIA NEI PAZIENTI CON DIABETE DI TIPO 2 E RIDOTTA FUNZIONE RENALE

  2019cites this paper
• MiR-133 inhibits kidney injury in rats with diabetic nephropathy via MAPK/ERK pathway.

  2019cites this paper
• Urinary heme oxygenase-1 as a new and early marker of diabetic nephropathy

  2019cites this paper
• Effect of sitagliptin on tubulointerstitial Wnt/β‐catenin signalling in diabetic nephropathy

  2019influential citation
• Protective Effect of Salidroside Against Diabetic Kidney Disease Through Inhibiting BIM-Mediated Apoptosis of Proximal Renal Tubular Cells in Rats

  2018cites this paper
• The Predictive Value of LCN2 (NGAL) in Renal Transplant Recipients

  2018cites this paper
• Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy

  2018cites this paper
• Evaluation value of neutrophil gelatinase‐associated lipocalin for the renal dysfunction of patients with chronic kidney disease: A meta‐analysis

  2018cites this paper
• Anti-fibrotic treatments: A review of clinical evidence.

  2018cites this paper